Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 14, Issue 6, Pages 1743-1752Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2018.04.012
Keywords
Melanin dots; T-1/T-2 dual mode contrast agent; Relaxivity; Gadolinium; Magnetic resonance imaging
Funding
- Office of Science (BER), U.S. Department of Energy [DE-SC0008397]
- NIH In vivo Cellular Molecular Imaging Center (ICMIC) [P50 CA114747]
- NSFC [81571747, 81371628]
- National Basic Research Program of China [2015CB931800]
- Hubei province nature science funding [2014CFB746]
Ask authors/readers for more resources
In this report, a novel T-1/T-2 dual modal nanoprobe based on highly efficient and bioinspired melanin dots (M-dots) with directly loading gadolinium (Gd-M-dots) for magnetic resonance imaging (MRI) is described. In vitro and in vivo investigations have revealed that Gd-M-dots showed nontoxicity and good biocompatibilitity. Gd-M-dots relaxivity values on 3 T were determined to be r(1) = 23.4 and r(2) = 123.3 mM(-1) s(-1), which were much higher than both Gd-DTPA (r(1) = 5.1, r(2) = 6.2 mM(-1) s(-1)) and Fe-M-dots (r(1 )= 1.2, r(2) = 2.1 mM(-1) s(-1)). For in vivo MRI, after injection of Gd-M-dots, simultaneous T-1 and T-2 contrast enhancement have been observed in the MRI of mice abdomen and mice bearing U87MG tumors. Furthermore, all the veins showed high signal intensity on T-1-weighted MRI and remained for 2 h. Overall, in vitro and in vivo studies indicate that Gd-M-dot with high r(1) relaxivity and r(2) relaxivity has high potential to he a promising nanoprobe for MR venography and molecular imaging. (C) 2018 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available